More than a year has passed since the first confirmed case of SARS-CoV-2 infection in the US was reported on January 20, 2020. What followed was an unprecedented year with nearly 30 million documented infections and more than 500 000 excess deaths in the US due to SARS-CoV-2. Alongside this devastation is the successful development and deployment of multiple safe and effective vaccines.1
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Carlos del Rio, MD, Emory University School of Medicine, 49 Jesse Hill Jr Dr, FOB, Room 201, Atlanta, GA 30303 (firstname.lastname@example.org).
Published Online: March 4, 2021. doi:10.1001/jama.2021.3760
Conflict of Interest Disclosures: Dr del Rio reports receiving grants from NIH/NIAID Emory Vaccine and Treatment Evaluation Unit. No other disclosures were reported.
You currently have no searches saved.
You currently have no courses saved.